209909-13-7

Basic information

• Product Name: 2-Chloro-6,7-difluoro-3-quinolinecarboxaldehyde
• Synonyms: 2-CHLORO-6,7-DIFLUORO-3-QUINOLINE CARBOXALDEHYDE;2-Chloro-6,7-difluoroquinoline-3-carbaldehyde
• CAS NO: 209909-13-7
• Molecular Formula: C₁₀H₄ClF₂NO
• Molecular Weight: 227.59
• Mol File: 209909-13-7.mol
• Article Data: 5

Chemical Properties

• Boiling Point: 344.847°C at 760 mmHg
• Flash Point: 162.358°C
• Appearance: /
• Density: 1.529
• Vapor Pressure: 0mmHg at 25°C
• Refractive Index: 1.643
• Storage Temp.: 2-8°C
• PKA: -3.16±0.50(Predicted)
• CAS DataBase Reference: 2-Chloro-6,7-difluoro-3-quinolinecarboxaldehyde(CAS DataBase Reference)
• NIST Chemistry Reference: 2-Chloro-6,7-difluoro-3-quinolinecarboxaldehyde(209909-13-7)
• EPA Substance Registry System: 2-Chloro-6,7-difluoro-3-quinolinecarboxaldehyde(209909-13-7)

Safety Data

• Safety Statements: 24/25
• Hazardous Substances Data: 209909-13-7(Hazardous Substances Data)

Usage

General Description

2-Chloro-6,7-difluoro-3-quinolinecarboxaldehyde is a chemical compound with the molecular formula C11H5ClF2NO and a molecular weight of 241.61 g/mol. It is a yellow solid with a strong, pungent odor. 2-Chloro-6,7-difluoro-3-quinolinecarboxaldehyde is used in the synthesis of pharmaceuticals, agrochemicals, and dyes. It is also used as an intermediate in the production of other chemicals. 2-Chloro-6,7-difluoro-3-quinolinecarboxaldehyde is considered to be harmful if swallowed, inhaled, or absorbed through the skin, and it may cause irritation to the respiratory system and skin. It should be handled and stored with appropriate safety precautions.

InChI:InChI=1/C10H4ClF2NO/c11-10-6(4-15)1-5-2-7(12)8(13)3-9(5)14-10/h1-4H

Upstream product

• 458-11-7 3,4-difluoroacetanilide 
• 68-12-2 N,N-dimethyl-formamide 

Downstream Products

• 186668-70-2 5-ethyl-9,10-difluoro-5-hydroxy-1,4,5,13-tetrahydro-3H,15H-oxepino[3',4':6,7]indolizino[1,2-b]quinoline-3,15-dione 

Relevant articles and documents

BICYCLIC DERIVATIVES AS CETP INHIBITORS

The present invention relates to novel compounds of formula (I): or a pharmaceutical composition thereof, with all the variables being defined in the text. The present invention further relates to the use of the compounds herein for treatment of or delay

New analogues of camptothecin, their use as medicaments and the pharmaceutical compositions containing them

A compound of the formula wherein the substituents are defined as in the specification which compounds are useful in the treatment of cancer.

Homocamptothecins: Synthesis and antitumor activity of novel E-ring- modified camptothecin analogues

Homocamptothecin (hCPT), a camptothecin (CPT) analogue with a seven membered β-hydroxylactone which combines enhanced plasma stability and potent topoisomerase I (Topo I) mediated activity, is an attractive template for the elaboration of new anticancer a